Back
Cellectar Biosciences, Inc. Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
32
CLRB
Cellectar Biosciences, Inc.
Last Price:
$3.15
Seasonality Move:
3.11%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
The current trend is relatively stagnant and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.
Cellectar Biosciences, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.07 | Buy |
| 20-day SMA: | 3.13 | Sell |
| 50-day SMA: | 3.26 | Sell |
| 200-day SMA: | 5.87 | Sell |
| 8-day EMA: | 3.12 | Sell |
| 20-day EMA: | 3.14 | Sell |
| 50-day EMA: | 3.45 | Sell |
| 200-day EMA: | 9.5 | Sell |
Cellectar Biosciences, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 47.45 | Sell |
| Chaikin Money Flow: | -88008 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.79 - 3.73) | Sell |
| Bollinger Bands (100): | (3.14 - 5.08) | Sell |
Cellectar Biosciences, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cellectar Biosciences, Inc. Stock
Is Cellectar Biosciences, Inc. Stock a Buy?
-
Cellectar Biosciences, Inc. share price is 3.08 while CLRB 8-day simple moving average is 3.07, which is a Buy signal.
-
The stock price of CLRB is 3.08 while Cellectar Biosciences, Inc. 20-day SMA is 3.13, which makes it a Sell.
-
Cellectar Biosciences, Inc. 50-day simple moving average is 3.26 while CLRB share price is 3.08, making it a Sell technically.
-
CLRB stock price is 3.08 and Cellectar Biosciences, Inc. 200-day simple moving average is 5.87, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
32
Cellectar Biosciences, Inc. (CLRB)
is a Sell
Is Cellectar Biosciences, Inc. a Buy or a Sell?
-
Cellectar Biosciences, Inc. stock is rated a SellThe current Cellectar Biosciences, Inc. [CLRB] share price is $3.08. The Score for CLRB is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences, Inc. Stock Info
Market Cap:
5.6M
Price in USD:
3.08
Share Volume:
99.7K
Cellectar Biosciences, Inc. 52-Week Range
52-Week High:
20.59
52-Week Low:
2.45
Sell
32
Cellectar Biosciences, Inc. (CLRB)
is a Sell
Cellectar Biosciences, Inc. Share Price Forecast
-
What is the Cellectar Biosciences, Inc. stock price today?The Cellectar Biosciences, Inc. stock price is 3.08 USD today.
-
Will CLRB stock go up or go down?Cellectar Biosciences, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cellectar Biosciences, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences, Inc. is overvalued.
Is Cellectar Biosciences, Inc. Stock a Buy?
-
Cellectar Biosciences, Inc. share price is 3.08 while CLRB 8-day exponential moving average is 3.12, which is a Sell signal.
-
The stock price of CLRB is 3.08 while Cellectar Biosciences, Inc. 20-day EMA is 3.14, which makes it a Sell.
-
Cellectar Biosciences, Inc. 50-day exponential moving average is 3.45 while CLRB share price is 3.08, making it a Sell technically.
-
CLRB stock price is 3.08 and Cellectar Biosciences, Inc. 200-day simple moving average is 9.50, creating a Sell signal.
Fundamental Analysis of Cellectar Biosciences, Inc.
Is Cellectar Biosciences, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and an increase next year of $2.43 per share.
Technical Analysis of Cellectar Biosciences, Inc.
Should I short Cellectar Biosciences, Inc. stock?
-
CLRB Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Cellectar Biosciences, Inc. is a Sell
-
Cellectar Biosciences, Inc. Relative Strength Index (RSI) is 47.45, which suggest Cellectar Biosciences, Inc. is oversold
-
The Bollinger Bands (25) for Cellectar Biosciences, Inc. is (2.79 - 3.73), which suggest Cellectar Biosciences, Inc. is a Sell
-
The Bollinger Bands (100) for Cellectar Biosciences, Inc. is (3.14 - 5.08), which suggest Cellectar Biosciences, Inc. is a Sell
* Cellectar Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.